Falcon Capital Acquisition Corp
Falcon Capital Acquisition — Sharecare — SPAC Merger (February 2021)
48 slides from Falcon Capital Acquisition's SPAC merger presentation, Feb 12, 2021
Slide 1: All Together Better
All t o g e the r better
Slide 2: Disclaimer
Dis c laimer 2 This investor presentation (“Investor Presentation”) is for informational purposes and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments of Sharecare Inc . (“Sharecare” or the “Company
Slide 3: Disclaimer (continued)
Disclaimer (continued) 3 Projections This Investor Presentation contains projected financial information with respect to Sharecare . Such projected financial information constitutes forward - looking information, is for illustrative purposes only and should not be relied upon as necessarily indicati
Slide 4: Proven Track Record
Proven Track Record ALL T OGETHER BETTER 1994 QDS, Founder Remote patient monitoring sold to Matria Healthcare 1998 WebMD, Founder Leading healthcare website sold for $4B 2007 HowStuffWorks, CEO Sold to Discovery Communications 4 2010 Sharecare, Founder, CEO and Chairman Comprehensive health and wel
Slide 5: Vision
V ision ALL T OGETHER BETTER Sharecare is a health & well - being digital hub that unifies all the elements of individual and community health so everyone can live better, longer . We provide an interoperable platform integrating fragmented point solutions and disparate stakeholders to foster a fric
Slide 6: Diverse Team of Innovators, Operators, and Unifiers
P am Shipley COO, GM Enterprise Laura Klein EVP/GM, Consumer Solutions Dawn Whaley President, Chief Marketing O ffi cer Naveen Saxena Chief Technology O ffi cer Natalie Schneider EVP/GM, Provider Solutions Medical Director, Behavioral Health Jud Brewer, MD, PhD Michael Crupain, MD, MPH Chief Medical O ffi
Slide 7: Sharecare Overview
Sharecare Overview ALL T OGETHER BETTER LIVING ROOM FINANCIAL • A comprehensive digital solution helping people build longer, better lives • Operating across three divisions: INVESTMENT PARTNERS EXAM ROOM W ORKPL A CE ENTERPRISE PR O VIDER CONSUMER SO L UTIONS SHARE C ARE B Y THE NUMBERS 7 2012 heal
Slide 8: Delivering Accelerated Growth with Significant Operating Leverage
8 Delivering Accelerated Growth with Significant Operating Leverage ALL T OGETHER BETTER $, in millions Note: excludes acquisition; Adjusted EBITDA adjusted to remove non - cash operating expenses (stock option compensation expense), severance and acquisition - related costs EBIT D A 8% 12% 16% A D
Slide 9: Category of One: Business Positioned for Growth and Scale
Category of One: Business Positioned for Growth and Scale C omp r ehens i v e Platform Diversified Revenue & Scale Data & Inn o v ation Innovative digital health platform based on person - centric design. Diversified portfolio with opportunity to capture $1B++ in incremental revenue from existing cu
Slide 10: Comprehensive Platform
Comprehensive Platform Qsharecare
Slide 11: Personalized Digital Platform Enabling Productized Engagement
11 ALL T OGETHER BETTER Personalized Digital Platform Enabling Productized Engagement MESSAGING M O TI V A TION MAN A GEMENT MEASUREMENT M O VEMENT C omp r ehens i v e Platform ENTERPRISE PR O VIDER CONSUMER SOLUTIONS Benefits Healthcare Digital Wellness/ Blue Zones Health Health Value - Payment Rem
Slide 12: Personalized Digital Platform Enabling Productized Engagement
2 1 ALL T OGETHER BETTER Personalized Digital Platform Enabling Productized Engagement MESSAGING M O TI V A TION MAN A GEMENT MEASUREMENT M O VEMENT C omp r ehens i v e Platform ENTERPRISE PR O VIDER CONSUMER SOLUTIONS Benefits Healthcare Digital Wellness/ Blue Zones Health Health Value - Payment Re
Slide 13: Diversified Revenue & Scale
13 Diversified Revenue & Scale
Slide 14: Enterprise: Fragmented Offerings Driving Cost & Vendor Fatigue
1 4 Behavioral Health Financial Well - Being Physical Activity/Wellness Sleep Smoking Cessation Provider Networks Onsite/Near - Site Incentives Food Logging Advocacy MSK Pharmacy Care Coordination Lifestyle Mgmt Communications Medication Adherence Biometric Screening Telehealth Second Opinion Medica
Slide 15: Enterprise: Integrated Solution Lowering Healthcare Costs
KEY P A Y OR CLIEN T S: 15 ENTERPRISE Integrated Solution Lowering Healthcare Costs, Improving Outcomes, and Increasing Satisfaction Revenue model: Recurring multi - year contracts with upsell opportunities. Pricing structure: PMPM, P er enrollee Client Base: 27 direct large employers, 9 health plan
Slide 16: Enterprise Land and Expand: Comprehensive Offering
Digital Therapeutic Programs incremental fee per enrollee Core Digital Platform PMPM Population Risk Stratification Member Engagement Incentives Management Existing Client Base Claims Ingestion ENTERPRISE Land and Expand: Comprehensive Offering to Improve Health Marketplace of Targeted $1B revenue op
Slide 17: Blue Zones Project Driving Community Well-Being Transformation
D iv er sifi e d Revenue & Scale ENTERPRISE Blue Zones Project Driving Community Well - Being Transformation Proven model optimizing the “life radius” where we live, work and play creating lead - gen and engagement for Sharecare digital platform Revenue model: Recurring multi - year contracts with u
Slide 18: Enterprise: Established Strategy to Drive Revenue Growth
ENTERPRISE Established Strategy to Drive Revenue Growth Utilizing an omni - channel approach to activating 7M+ eligible lives in digital therapeutics across currently contracted client base New digital therapeutics product offerings • Increase digital therapeutics programs offerings for 2021 • Hyper
Slide 19: Provider: Improving Efficiency and Better Patient Care
19 KEY PR O VIDER CLIEN T S: PROVIDER Improving Efficiency and Better Patient Care Revenue model: Recurring multi - year contracts with upsell opportunities Pricing structure differs by product: Gainshare, SaaS platform fee, Per record request Client base: 6,000 hospitals & physician practices, 75+ he
Slide 20: Provider Land and Expand: Comprehensive Service Offering
PROVIDER Land and Expand: Comprehensive Provider Service Offering D iv er sifi e d Revenue & Scale • • • • • Release of information (ROI) Medical record requests & retrieval Medical record audits & reviews Dynamic insights (AI) Forms management Core Service HEA L TH INFORM A TION MANAGEMENT • • • • H
Slide 21: Proven Growth with New Products and Deployment into Clients
2016 2017 2018 2019 2020 Historical growth in audit supports thesis to upsell new products into current customer base 27 21 13 8 4 +106% +59% +63% +31% Annual Audit Revenue $, in millions 61% C A GR Contracted Hospital Partner 0 225 450 675 900 2016 2017 2018 2019 2020 Proven ability to “land and ex
Slide 22: Driving Significant Near-Term Revenue Growth and Margin Expansion
Expand product portfolio • Deploy value - based care and payment integrity across 6,000 clients • Integrate denial management services & remote patient monitoring • Sharecare - enabled clinician to close gaps - in - care Expand customer footprint • Continue momentum with organic growth with new heal
Slide 23: Consumer Solutions: Key Strategic Driver for Consumer Acquisition
23 KEY LIFE SCIENCES CLIEN T S: CONSUMER SOLUTIONS Key Strategic Driver for Consumer Acquisition, Content Creation and Data - driven Digital Activation 100M first - party user database Significant content library and video capabilities ( 265K+ articles/slideshows, 48K+ original videos, 155M emails d
Slide 24: Consumer Solutions Land and Expand: Condition Expertise Driven by Data
CONSUMER SOLUTIONS Land and Expand: Condition Expertise Driven by Data CLINICAL RESEARCH OR G ANIZ A TION (CRO) GROWTH • Enable new decentralized and digital clinical trials in the $50B CRO mar k et • Offer expansive reach & AI for sophisticated recruitment • Improve patient experience/retention thr
Slide 25: Driving Growth with Core Life Sciences Clients and New Initiatives
CONSUMER SOLUTIONS Driving Growth with Core Life Sciences Clients and New Initiatives Retention and growth of existing life sciences clients • Expand beyond our current life sciences brand campaigns • Contract renewals with significant increases in commitments • 80%+ retention rate Focus on integrat
Slide 26: Data & Innovation
Data & Inn o v ation 26
Slide 27: Invested in Data to Drive Personalization, Engagement, and New Products
Data & Inn o vation COMMUNITY WELL - BEING INDEX Invested in Data to Drive Personalization, Engagement, and New Products Unique differentiator the healthy choice the easy choice for employers, health plans, health systems, and community leaders 27
Slide 28: New Revenue Opportunities with Health Security
Data & Inn o vation HEA L TH SECURITY New Revenue Opportunities & Global Branding with Health Security Health security for an enterprise is equivalent to what cyber security means for enterprise’s IT department Facility & Employee Readiness A platform to help unify and verify the different approache
Slide 29: Health Security: Digital Vaccine
Data & Inn o vation HEA L TH SECURITY New Revenue Opportunities & Global Branding with Health Security Health security for an enterprise is equivalent to what cyber security means for enterprise’s IT department Digital Vaccine A comprehensive package for vaccine adherence with award - winning conten
Slide 30: Acquisition: doc.ai - Deep Expertise in Artificial Intelligence
SHARE C ARE + DOC.AI Acquisition: Doc.ai - Deep Expertise in Artificial Intelligence Sam De Brouwer Co - Founder & Chief Executive O ffi cer Walter De Brouwer Co - Founder & Chief Scientific O ffi cer Nirav R. Shah, MD, MPH Chief Medical O ffi cer Akshay Sharma Chief Technology O ffi cer Eric T opol, M D ,
Slide 31: Data Driving Enhanced Digital Products & Services
Engagement data Social data Influencer data Clinical/claims data Device data Community assessments Health Security data Social determinants + ANTICIPATE CU S T OMER NEEDS Prescribe actions for customer growth More powerful AI and machine learning ENHANCED DIGI T AL PRODUC T S & SE R VICES Health Car
Slide 32: Differentiated Financial Performance
Di ff e r entia t e d Financial Performance 32
Slide 33: Key Financial Highlights
33 Key Financial Highlights Dif f e r entia t e d Financial Performance Revenue Visibility • • Recurring revenue driven by multi - year contracts 95% booked against 2021 budget with significant visibility into 2022 • • Adjusted EBITDA positive with continued operating leverage Medium - term opportun
Slide 34: Delivering Accelerated Growth
34 Delivering Accelerated Growth Achieve scale profitability through significant operating leverage Dif f e r entia t e d Financial Performance Projected Financial Summary NOTE: Adjusted EBITDA reflects removal of non - cash operating expenses (stock option compensation expense), severance and acqui
Slide 35: 2020E-2021E Revenue Bridge
9 5 % of 2 0 21 R e v enue is C ont r a c te d as of T o d a y Dif f e r entia t e d Financial Performance Focusing the growth story: Base case provides substantial growth with further opportunity for upside 2020E – 2021E Revenue Bridge ($, in millions) $5 $330 $38 $23 $396 Enterprise Provider Consu
Slide 36: Sustained Growth into 2022 and Beyond
Sustained Growth into 2022 and Beyond Dif f e r entia t e d Financial Performance Key business initiatives driving growth in 2021 projected to continue through 2022 2021E – 2022E Revenue Bridge ($, in millions) 2021E total $396 $81 $27 $9 $512 Enterprise Provider Consumer 2022E total Enterprise: 36
Slide 37: Successful Execution of Repositioning and Integration
Successful Execution of Repositioning and Integration Dif f e r entia t e d Financial Performance Unprofitable Profitable 37 • Planned for over $90M degradation of unprofitable, legacy contracts while focusing on digitally - enabled revenue streams and high - value clients • Retained $150M in revenu
Slide 38: Historical Financial Summary
Historical Financial Summary ($, in millions) Dif f e r entia t e d Financial Performance 38 2017A 2018A 2019A 2020E Enterprise Solutions (Reported) $241 $210 $203 $190 Total Revenue (Reported) $347 $342 $340 $330 Enterprise Solutions (Normalized) $151 $160 $181 $190 Total Revenue (Normalized) $257
Slide 39: Built for Scale and Accelerated Revenue Growth
Built for Scale and Accelerated Revenue Growth Dif f e r entia t e d Financial Performance • • New digital therapeutics programs Market entry into adjacent verticals • Establish partnerships to continue to bring leading offerings to our customers • Deliver innovative AI solutions • Penetration of He
Slide 40: Transaction Overview
T r ansa c tion Overview 40
Slide 41: Pro Forma Capitalization and Ownership
41 Pro Forma Capitalization and Ownership K ey Deal Considerations: T r ansa c tion Overview 1 Gives effect to surrender 15% of Founder shares held by Sponsor and a transfer of 5% to a Sharecare charity. 75% of the remaining 80% to convert to Class A shares upon closing of the merger. Balance subjec
Slide 42: Attractive Entry Point for Investors
42 Attractive Entry Point for Investors T r ansa c tion Overview Growth Adjusted 1 0.30 x 1.07 x 0.69 x 0 .39 x 0 .50 x 0.48 x CY20 - 21E Growth 1 9 .8 % 4 0 .6 % 25.2 % 28 . 1 % 22.8 % 11.5 % Source: Wall Street Research, IBES and Market data as of 22 - Jan - 2021, Sharecare management projections
Slide 43: Category of One
sharecare Category of One 43 Qsharecare
Slide 44: Category of One
44 Category of One C omp r ehens i v e Platform Diversified Revenue & Scale Data & Inn o v ation Innovative digital health platform based on person - centric design. Diversified portfolio with opportunity to capture $1B++ in incremental revenue from existing customers . At the intersection of techno
Slide 45: Appendix
Appendix @sharecare
Slide 46: Sharecare Risk Factors
APPENDIX Sharecare Risk Factors 46 Investing in the PIPE offering (the “Offering”) involves a high degree of risk. Below is a non - comprehensive list of certain risks and uncertainties, and there are various risks and uncertainties associated with Sharecare, Inc. (the “Company”). You should careful
Slide 47: Sharecare Risk Factors
APPENDIX Sharecare Risk Factors 47 • • • • Our sales and the success of our marketing efforts depend significantly on our ability to call upon our current clients to provide positive references to new, potential clients. Failure to obtain such references, as a result of the dissatisfaction of our cu
Slide 48: Reconciliation to Historical Adjusted EBITDA
Dif f e r entia t e d Financial Performance 48 2017A 2018A 2019A Net Loss ($43) ($55) ($40) Interest Income (0) (0) (0) Interest Expense 19 26 29 L oss on Share of Equity Method Investment 1 2 – Other Expense 0 0 1 Income T ax (Expense) Benefit 3 0 0 L oss from Operations ($20) ($27) ($10) Depreciat